{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:41:31Z","timestamp":1792478491007,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03437-w","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:16:03Z","timestamp":1792476963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bladder preservation is still feasible in the rare aggressive small cell carcinoma subtype"],"prefix":"10.1007","volume":"43","author":[{"given":"Yahia","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Aboulkassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Gamal","family":"Ashour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Amin","family":"AbouGabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Elsayed","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4678-9145","authenticated-orcid":false,"given":"Mohammad","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"3437_CR1","doi-asserted-by":"publisher","unstructured":"Vlachou E III, Baraban BAJ, Nadal E, Hoffman-Censits R. J. Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer. Am Soc Clin Oncol Educ B [Internet]. 2024;44:e438640. Available from: https:\/\/doi.org\/10.1200\/EDBK_438640","DOI":"10.1200\/EDBK_438640"},{"key":"3437_CR2","doi-asserted-by":"publisher","unstructured":"Kamitani R, Ando T, Hanai K, Tanaka A, Kashizaki F, Sekido Y et al. Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab. BMC Urol [Internet]. 2022 [cited 2024 Mar 8];22:1\u20135. Available from: https:\/\/link.springer.com\/articles\/https:\/\/doi.org\/10.1186\/s12894-022-01130-4","DOI":"10.1186\/s12894-022-01130-4"},{"key":"3437_CR3","doi-asserted-by":"publisher","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin [Internet]. 2011 [cited 2023 Jan 16];61:69\u201390. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.3322\/caac.20107","DOI":"10.3322\/caac.20107"},{"key":"3437_CR4","doi-asserted-by":"publisher","unstructured":"LOPEZ JI, ANGULO JC, FLORES N, TOLEDO JD. Small cell carcinoma of the urinary bladder. A clinicopathological study of six cases. Br J Urol [Internet]. 1994 [cited 2023 Jan 16];73:43\u20139. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/j.1464-410X.1994.tb07454.x","DOI":"10.1111\/j.1464-410X.1994.tb07454.x"},{"key":"3437_CR5","doi-asserted-by":"publisher","unstructured":"Koay EJ, Teh BS, Paulino AC, Butler EB. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder. Epidemiology, prognostic variables, and treatment trends. Cancer [Internet]. 2011 [cited 2023 Jan 16];117:5325\u201333. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1002\/cncr.26197","DOI":"10.1002\/cncr.26197"},{"key":"3437_CR6","doi-asserted-by":"publisher","unstructured":"Ismaili N, Heudel PE, Elkarak F, Kaikani W, Bajard A, Ismaili M et al. Outcome of recurrent and metastatic small cell carcinoma of the bladder. BMC Urol [Internet]. 2009 [cited 2023 Jan 16];9:1\u20138. Available from: https:\/\/link.springer.com\/articles\/https:\/\/doi.org\/10.1186\/1471-2490-9-4","DOI":"10.1186\/1471-2490-9-4"},{"key":"3437_CR7","doi-asserted-by":"publisher","unstructured":"Chen Z, Liu Q, Chen R, Liu Z, Li M, Ling Q et al. Clinical analysis of small cell carcinoma of the bladder in Chinese: Nine case reports and literature reviews. World J Surg Oncol [Internet]. 2017 [cited 2024 Mar 8];15:1\u20137. Available from: https:\/\/wjso.biomedcentral.com\/https:\/\/doi.org\/10.1186\/s12957-016-1079-y","DOI":"10.1186\/s12957-016-1079-y"},{"key":"3437_CR8","doi-asserted-by":"publisher","unstructured":"Siefker-Radtke AO, Kamat AM, Grossman HB, Williams DL, Qiao W, Thall PF et al. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide\/doxorubicin and etoposide\/cisplatin in small-cell urothelial cancer. J Clin Oncol [Internet]. 2009 [cited 2024 Aug 18];27:2592\u20137. Available from: https:\/\/doi.org\/10.1200\/JCO.2008.19.0256","DOI":"10.1200\/JCO.2008.19.0256"},{"key":"3437_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.clgc.2022.05.005","volume":"20","author":"MY Teo","year":"2022","unstructured":"Teo MY, Guercio BJ, Arora A, Hao X, Regazzi AM, Donahue T, et al. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy. Clin Genitourin Cancer. 2022;20:431\u201341.","journal-title":"Clin Genitourin Cancer"},{"key":"3437_CR10","doi-asserted-by":"publisher","unstructured":"Choi S, Campbell MT, Shah AY, Navai N, Kamat AM, Colin PN, Dinney. Quynh Nguyen and AOS-R. Prophylactic cranial irradiation (PCI) significantly decreases risk of brain metastases in patients with bulky, higher stage small-cell urothelial cance. J Clin Oncol [Internet]. 2019;37:486. Available from: https:\/\/doi.org\/10.1200\/JCO.2019.37.7_suppl.486","DOI":"10.1200\/JCO.2019.37.7_suppl.486"},{"key":"3437_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clgc.2012.11.002","volume":"11","author":"S Thota","year":"2013","unstructured":"Thota S, Kistangari G, Daw H, Spiro T. A Clinical Review of Small-Cell Carcinoma of the Urinary Bladder. Clin Genitourin Cancer. 2013;11:73\u20137.","journal-title":"Clin Genitourin Cancer"},{"key":"3437_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.eururo.2012.04.020","volume":"64","author":"SP Lynch","year":"2013","unstructured":"Lynch SP, Shen Y, Kamat A, Grossman HB, Shah JB, Millikan RE, et al. Neoadjuvant Chemotherapy in Small Cell Urothelial Cancer Improves Pathologic Downstaging and Long-term Outcomes: Results from a Retrospective Study at the MD Anderson Cancer Center. Eur Urol. 2013;64:307\u201313.","journal-title":"Eur Urol"},{"key":"3437_CR13","doi-asserted-by":"publisher","unstructured":"Galsky MD, Hahn NM, Rosenberg J, Sonpavde G, Hutson T, Oh WK et al. Treatment of Patients With Metastatic Urothelial Cancer Unfit for Cisplatin-Based Chemotherapy. J Clin Oncol [Internet]. 2011 [cited 2025 Jul 21];29:2432\u20138. Available from: https:\/\/doi.org\/10.1200\/JCO.2011.34.8433","DOI":"10.1200\/JCO.2011.34.8433"},{"key":"3437_CR14","doi-asserted-by":"publisher","unstructured":"Cockcroft DW, Gault MH. Prediction of Creatinine Clearance from Serum Creatinine. Nephron [Internet]. 1976 [cited 2025 Jul 21];16:31\u201341. Available from: https:\/\/doi.org\/10.1159\/000180580","DOI":"10.1159\/000180580"},{"key":"3437_CR15","unstructured":"Raspollini MR, Comperat EM, Lopez-Beltran A, Montironi R, Cimadamore A, Tsuzuki T et al. News in the classification of WHO 2022 bladder tumors. Pathologica [Internet]. 2022 [cited 2024 Jul 22];115:32\u201340. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36704871\/"},{"key":"3437_CR16","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.euf.2017.09.001","volume":"4","author":"BW Fischer-Valuck","year":"2018","unstructured":"Fischer-Valuck BW, Rao YJ, Henke LE, Rudra S, Hui C, Baumann BC, et al. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder. Eur Urol Focus. 2018;4:900\u20136.","journal-title":"Eur Urol Focus"},{"key":"3437_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijrobp.2011.05.039","volume":"83","author":"EJ Koay","year":"2012","unstructured":"Koay EJ, Teh BS, Paulino AC, Butler EB. Treatment Trends and Outcomes of Small-Cell Carcinoma of the Bladder. Int J Radiat Oncol. 2012;83:64\u201370.","journal-title":"Int J Radiat Oncol"},{"key":"3437_CR18","doi-asserted-by":"publisher","unstructured":"Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y et al. Clinical Outcomes Following Radical Cystectomy for Primary Nontransitional Cell Carcinoma of the Bladder Compared to Transitional Cell Carcinoma of the Bladder. J Urol [Internet]. 2006 [cited 2024 Aug 17];175:2048\u201353. Available from: https:\/\/www.auajournals.orghttps:\/\/doi.org\/10.1016\/S0022-5347%2806%2900317-X","DOI":"10.1016\/S0022-5347%2806%2900317-X"},{"key":"3437_CR19","doi-asserted-by":"crossref","unstructured":"Schreiber D, Rineer J, Weiss J, Leaf A, Karanikolas N, Rotman M et al. Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database. Am J Clin Oncol Cancer Clin Trials [Internet]. 2013 [cited 2024 Aug 17];36:126\u201331. Available from: https:\/\/journals.lww.com\/amjclinicaloncology\/fulltext\/2013\/04000\/characterization_and_outcomes_of_small_cell.5.aspx","DOI":"10.1097\/COC.0b013e3182438c71"},{"key":"3437_CR20","doi-asserted-by":"crossref","unstructured":"Edward Blomjos C, PhD MD, Winand Vos MD, Herman J, de Voogt MD, PhD P, Van Der Valk MD, PhD, Chris JLM, Meijer. MD P. Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer [Internet]. 1989;64:1347\u201357. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/1097-0142%2819890915%2964%3A6%3C1347%3A%3AAID-CNCR2820640629%3E3.0.CO%3B2-Q","DOI":"10.1002\/1097-0142(19890915)64:6<1347::AID-CNCR2820640629>3.0.CO;2-Q"},{"key":"3437_CR21","doi-asserted-by":"crossref","unstructured":"Kalemkerian GP, Loo BW, Akerley W, Attia A, Bassetti M, Boumber Y et al. NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. J Natl Compr Cancer Netw [Internet]. 2018 [cited 2024 Jul 22];16:1171\u201382. Available from: https:\/\/jnccn.org\/view\/journals\/jnccn\/16\/10\/article-p1171.xml","DOI":"10.6004\/jnccn.2018.0079"},{"key":"3437_CR22","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1097\/00005392-199805000-00058","volume":"159","author":"JR Mackey","year":"1998","unstructured":"Mackey JR, Au HJ, Hugh J, Venner P, GENITOURINARY SMALL CELL. CARCINOMA: DETERMINATION OF CLINICAL AND THERAPEUTIC FACTORS ASSOCIATED WITH SURVIVAL. J Urol. 1998;159:1624\u20139.","journal-title":"J Urol"},{"key":"3437_CR23","doi-asserted-by":"crossref","unstructured":"Lohrisch C, Murray N, Pickles T, Sullivan L. Small Cell Carcinoma of the Bladder Long Term Outcome with Integrated Chemoradiation. Cancer [Internet]. 1999 [cited 2024 Aug 18];68:2346\u201352. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11<2346::AID-CNCR24>3.0.CO;2-5"},{"key":"3437_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.urology.2004.09.049","volume":"65","author":"A Bex","year":"2005","unstructured":"Bex A, Nieuwenhuijzen JA, Kerst M, Pos F, Van Boven H, Meinhardt W, et al. Small cell carcinoma of bladder: A single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology. 2005;65:295\u20139.","journal-title":"Urology"},{"key":"3437_CR25","doi-asserted-by":"publisher","unstructured":"Bex A, Vries R, Pos F, Kerst M, Horenblas S. Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. World J Urol [Internet]. 2009 [cited 2024 Dec 20];27:101\u20136. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s00345-008-0304-x","DOI":"10.1007\/s00345-008-0304-x"},{"key":"3437_CR26","doi-asserted-by":"publisher","unstructured":"Asmis TR, Reaume MN, Dahrouge S, Malone S. Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center. BJU Int [Internet]. 2006 [cited 2024 Dec 20];97:711\u20135. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06041.x","DOI":"10.1111\/j.1464-410X.2006.06041.x"},{"key":"3437_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.humpath.2018.05.005","volume":"79","author":"G Wang","year":"2018","unstructured":"Wang G, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Dinney CP, et al. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol. 2018;79:57\u201365.","journal-title":"Hum Pathol"},{"key":"3437_CR28","doi-asserted-by":"publisher","unstructured":"Horn L, Mansfield AS, Szcz\u0119sna A, Havel L, Krzakowski M, Hochmair MJ et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med [Internet]. 2018 [cited 2024 Jul 22];379:2220\u20139. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa1809064","DOI":"10.1056\/NEJMoa1809064"},{"key":"3437_CR29","first-page":"1724","volume":"12","author":"H Shimizu","year":"2020","unstructured":"Shimizu H, Uda M, Okuda Y, Yamamoto Y, Kajikawa H, Sawada S. A Rare Case of Small Cell Carcinoma of the Urinary Bladder. Cureus [Internet]. 2020;12:1724\u20136. Available from: \/pmc\/articles\/PMC7362666\/.","journal-title":"Cureus [Internet]"},{"key":"3437_CR30","doi-asserted-by":"publisher","unstructured":"Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M et al. Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer. N Engl J Med [Internet]. 2007 [cited 2024 Dec 20];357:664\u201372. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa071780","DOI":"10.1056\/NEJMoa071780"},{"key":"3437_CR31","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/annonc\/mdq225","volume":"21","author":"A Bex","year":"2010","unstructured":"Bex A, Sonke GS, Pos FJ, Brandsma D, Kerst JM, Horenblas S. Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review. Ann Oncol. 2010;21:2240\u20135.","journal-title":"Ann Oncol"},{"key":"3437_CR32","doi-asserted-by":"crossref","unstructured":"Mollica V, Massari F, Andrini E, Rosellini M, Marchetti A, Nuvola G et al. Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis. Curr Oncol [Internet]. 2022 [cited 2024 Dec 20];29:5846\u201354. Available from: https:\/\/www.mdpi.com\/1718-7729\/29\/8\/461\/htm","DOI":"10.3390\/curroncol29080461"},{"key":"3437_CR33","unstructured":"Basile G, de Angelis M, Leni R, Re C, Longoni M, Mari A et al. Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review. Minerva Urol Nephrol [Internet]. 2023 [cited 2026 Jun 8];75:278\u201388. Available from: https:\/\/www.minervamedica.it\/en\/journals\/minerva-urology-nephrology\/article.php?cod=R19Y2023N03A0278"},{"key":"3437_CR34","doi-asserted-by":"crossref","unstructured":"Claps F, Biasatti A, Di Gianfrancesco L, Ongaro L, Giannarini G, Pavan N et al. The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature. J Clin Med [Internet]. 2024 [cited 2026 Jun 8];13:4349. Available from: https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4349\/htm.","DOI":"10.3390\/jcm13154349"},{"key":"3437_CR35","doi-asserted-by":"publisher","unstructured":"\u015alusarczyk A, Moschini M, Krajewski W, Scilipoti P, Ca\u00f1o Velasco J, Mertens LS et al. Bladder Tumor Location Matters: Trigone and Bladder Neck Involvement Predict Worse Oncological Outcomes in High-Grade Non-Muscle-Invasive Bladder Cancer. Ann Surg Oncol [Internet]. 2026 [cited 2026 Jun 8];1\u201314. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1245\/s10434-026-19476-6","DOI":"10.1245\/s10434-026-19476-6"},{"key":"3437_CR36","unstructured":"van Gennep EJ, Claps F, Bostrom PJ, Shariat SF, Neuzillet Y, Zlotta AR et al. Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy. Bl Cancer [Internet]. 2024 [cited 2026 Jun 8];10:119\u201332. Available from: https:\/\/scholar.google.com\/scholar_url?url=https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/BLC-230086&hl=en&sa=T&oi=ucasa&ct=ufr&ei=4B4narCFHuyE6rQP09y-0A4&scisig=ANDmEU77d0r__BZVo75d4qrQOQZ3"},{"key":"3437_CR37","doi-asserted-by":"publisher","unstructured":"Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Boormans JL, Eckstein M et al. Risk factors associated with positive surgical margins\u2019 location at radical cystectomy and their impact on bladder cancer survival. World J Urol [Internet]. 2021 [cited 2026 Jun 8];39:4363\u201371. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00345-021-03776-5","DOI":"10.1007\/s00345-021-03776-5"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03437-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:16:08Z","timestamp":1792476968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03437-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["3437"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03437-w","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All human-related procedures were performed in accordance with the ethical principles stated in the Declaration of Helsinki. The manuscript complies with the journal\u2019s submission guidelines. The work is original, has not been published previously, and is not under consideration for publication elsewhere. All authors have reviewed and approved the final manuscript and declare no conflicts of interest.","order":1,"name":"Ethics","label":"Accordance","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was carried out after approval by the National Cancer Institute- Cairo University, Egypt Institutional Review Board (I.R.B. # CP 2302-505-040). This type of study did not require patients' consent.","order":4,"name":"Ethics","label":"Ethical Approval & patients consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All personal information has been made anonymous. No consenting being a retrospective study, and the study did not add any risk to the patients.","order":5,"name":"Ethics","label":"Patients\u2019 confidentiality and consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"339"}}